Glucosa Mein (Glucose Monohydrate)

Glucosa Mein is indicated for several clinical situations where rapid glucose supplementation or fluid replacement is required.

• Treatment of hypoglycemia in patients unable to take oral glucose.
• Intravenous fluid replacement for dehydration or blood loss.
• Component of parenteral nutrition regimens.
• Support during surgical procedures to maintain blood glucose levels.
• Management of electrolyte imbalances when combined with appropriate salts.

Glucosa Mein may cause a range of reactions, most of which are related to its osmolarity and glucose content.

Common

• Mild hyperglycemia that resolves with monitoring.
• Transient nausea or vomiting after infusion.
• Local irritation or pain at the injection site.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Allergic reaction such as urticaria, rash, or anaphylaxis.
• Fluid overload causing pulmonary edema in susceptible patients.

When using Glucosa Mein, clinicians should consider patient‑specific factors and monitor for potential complications.

• Assess blood glucose levels before and during infusion.
• Use caution in patients with renal or cardiac insufficiency due to risk of fluid overload.
• Adjust infusion rate in diabetic patients to avoid hyperglycemia.
• Verify compatibility with other IV solutions to prevent precipitation.
• Store the product according to manufacturer instructions to maintain sterility.

Glucosa Mein can interact with other medications or clinical conditions, requiring careful management.

Avoid

• Co‑administration with rapid‑acting insulin without glucose monitoring.
• Use with hypertonic solutions that may exacerbate hyperglycemia.

Use with caution

• Concurrent use of diuretics that affect fluid balance.
• Patients receiving corticosteroids, which can raise blood glucose.
• Combination with other carbohydrate‑containing IV fluids.
• Administration alongside beta‑blockers that mask hypoglycemia symptoms.